Effectiveness Of Bnt162b2 (pfizer-biontech) Mrna Vaccination Against Multisystem Inflammatory Syndrome In Children Among Persons Aged 12-18 Years - United States, July-december 2021

Authors

• Laura D. Zambrano, Centers for Disease Control and Prevention
• Margaret M. Newhams, Children's Hospital Boston
• Samantha M. Olson, Centers for Disease Control and Prevention
• Natasha B. Halasa, Vanderbilt University Medical Center
• Ashley M. Price, Centers for Disease Control and Prevention
• Julie A. Boom, Texas Children's Hospital Houston
• Leila C. Sahni, Texas Children's Hospital Houston
• Satoshi Kamidani, Emory University School of Medicine
• Keiko M. Tarquinio, Emory University School of Medicine
• Aline B. Maddux, University of Colorado School of Medicine
• Sabrina M. Heidemann, Central Michigan University
• Samina S. Bhumbra, Indiana University School of MedicineFollow
• Katherine E. Bline, Nationwide Children’s Hospital
• Ryan A. Nofziger, Akron Children's Hospital
• Charlotte V. Hobbs, University of Mississippi Medical Center
• Tamara T. Bradford, LSU Health Sciences Center - New OrleansFollow
• Natalie Z. Cvijanovich, UCSF Benioff Children's Hospital Oakland
• Katherine Irby, Arkansas Children's Hospital
• Elizabeth H. MacK, Medical University of South Carolina
• Melissa L. Cullimore, Children's Hospital and Medical Center
• Pia S. Pannaraj, University of Southern California
• Michele Kong, The University of Alabama at Birmingham
• Tracie C. Walker, UNC School of Medicine
• Shira J. Gertz, Saint Barnabas Medical Center
• Kelly N. Michelson, Northwestern University Feinberg School of Medicine
• Melissa A. Cameron, Rady Children's Hospital
• Kathleen Chiotos, The Children's Hospital of Philadelphia
• Mia Maamari, UT Southwestern Medical School

Document Type

Article

Publication Date

1-7-2022

Publication Title

Morbidity and Mortality Weekly Report

First Page

52

Last Page

58

PubMed ID

35025852

Volume

71

Issue

2

Recommended Citation

Zambrano, Laura D.; Newhams, Margaret M.; Olson, Samantha M.; Halasa, Natasha B.; Price, Ashley M.; Boom, Julie A.; Sahni, Leila C.; Kamidani, Satoshi; Tarquinio, Keiko M.; Maddux, Aline B.; Heidemann, Sabrina M.; Bhumbra, Samina S.; Bline, Katherine E.; Nofziger, Ryan A.; Hobbs, Charlotte V.; Bradford, Tamara T.; Cvijanovich, Natalie Z.; Irby, Katherine; MacK, Elizabeth H.; Cullimore, Melissa L.; Pannaraj, Pia S.; Kong, Michele; Walker, Tracie C.; Gertz, Shira J.; Michelson, Kelly N.; Cameron, Melissa A.; Chiotos, Kathleen; and Maamari, Mia, "Effectiveness Of Bnt162b2 (pfizer-biontech) Mrna Vaccination Against Multisystem Inflammatory Syndrome In Children Among Persons Aged 12-18 Years - United States, July-december 2021" (2022). School of Medicine Faculty Publications. 1357.
https://digitalscholar.lsuhsc.edu/som_facpubs/1357
10.15585/MMWR.MM7102E1